Trisodium Citrate Dihydrate (E331(iii)) CAS: 6132-04-3
Related Insights
US Petrochemical Plant Shutdowns: What Halts in PS, PVC and Styrene Production Mean for Chemical Buyers
Four major US chemical companies suspended production lines for polystyrene, PVC, styrene and related products during early July 2026. Procurement teams should evaluate how reduced operating capacity may affect product availability, regional pricing and future sourcing strategies.
SABIC’s Q3 Supply Calendar: Saudi Export Strategy Sets Global Chemical Prices
SABIC’s Q3 supply calendar has emerged as a key indicator for polymer and chemical flows worldwide, with Ras Tanura’s logistics network playing a pivotal role. The company’s allocation decisions influence pricing, inventory levels, and competitive dynamics across major export markets.
UK Joins Hormuz Escort Coalition to Secure Gulf Chemical Trade
The UK’s entry into the Hormuz escort coalition is set to slash war‑risk insurance costs and strengthen supply chains for Gulf‑origin chemical imports in H2 2026. By bolstering maritime security, Britain can ensure safer, more reliable logistics for its critical chemical sector.
Aluminium and Gulf Metals: Emirates Global Aluminium and Alba Restart Watch
The 2026 Hormuz crisis stranded two of the world’s largest aluminium smelters — Emirates Global Aluminium and Alba Bahrain — quietly disrupting global supply for automotive, aerospace, and packaging manufacturers. With Gulf shipping conditions improving, aluminium logistics may recover faster than petrochemical markets in early H2 2026.
Sulfur Supply Recovery: Gulf Refinery By-Product and the 45% Global Share That Was Offline
The Hormuz crisis disrupted nearly 45% of global sulfur supply as Gulf refinery by-product exports collapsed for months. With vessel movement now improving, sulfur and sulfuric acid buyers may finally see the first meaningful cost relief in August after one of 2026’s most overlooked supply chain disruptions.
Pharmaceutical Supply Chain: H1 2026 Closing Risk Assessment
The first half of 2026 exposed major vulnerabilities in pharmaceutical supply chains. API concentration, shipping disruptions, and logistics risks are reshaping procurement strategies for H2 2026 and beyond.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.